We are excited to announce the release of MBC DART (Discovery & Accelerating Research Together): Insight to Impact — A Strategic Action Plan for metastatic #breastcancer@mbcalliance@washumedicine
https://t.co/DislYnj4iT
Josh Newby’s wife faced breast cancer while pregnant with their second daughter. Years later, he shared the relief of her latest negative test.
What has a cancer breakthrough meant to your family?
New episode November 9. Watch Building the Noise:
https://t.co/g83h1aYwRQ
#BuildingTheNoise #BreastCancer #CancerResearch #PatientStories #JoshNewby
The person you disagree with could be your greatest collaborator.
Josh Newby reminds us that meaningful progress in healthcare advocacy starts with listening, even when conversations are uncomfortable.
Watch: https://t.co/AnaAzLKdkt
#BuildingTheNoise#PatientAdvocacy
New Episode! "Building The Noise with Josh Newby: EPISODE 025"
Josh Newby spent years working in breast cancer advocacy. Then his wife was diagnosed with early-stage breast cancer while pregnant wit…
Player links & show notes: https://t.co/qtjOdeDyQ2
Breast cancer completely cut out of the NIH funding for vaccines. The largest killer of women. We deserve better. @NIH@SecKennedy@FLOTUS@KomenAdvocacy where is the outrage??
https://t.co/mEKUlPLJxb
Living with metastatic breast cancer takes more than clinical care — it takes community. Siteman Cancer Center’s MBC Empowerment Initiative connects patients with resources, support groups and a team that understands. @WashUMedicine https://t.co/HulElTmKLX
We are excited to announce we have a two day event planned for MBC AWARENESS DAY #BreastCancerAwarenessMonth . Day 1 in Houston and day two in St. Louis . Both will also be available online as well . Click the link for more details and get registered.
https://t.co/VxyqZao5Ho
Thrilled to see this in print. Honored to partner with @elmayermd@stolaney1 and our fabulous colleagues and partners at Roche/Genentech on this practice changing trial. Combo vs combo proves a more effective ET for mESR1 dse. @OncoAlert@OncBrothers
In a recent guest post, Individual Advocate Member Marybeth Gilliam reflects on why having patient advocates “in the room” matters—and how access to scientific meetings can help patients feel more informed, empowered, and hopeful.
Read her post: https://t.co/zrU4nE8BPE
Katie E. is sharing her experiencing living with MBC and the invisible side effects that take their toll. Explore her story, and those of others living with MBC, through our international storytelling project, #ThisIsMyMBC.
Explore more: https://t.co/DXCzNKeV3R
Now available! 📚 The Insider’s Guide to Metastatic Breast Cancer provides information about approved therapies, scientific studies, cutting edge research, clinical trials, and palliative care.
Learn more about the author & get a free PDF: https://t.co/Fn09E4wbC5
We celebrate the life and work of advocate member Elissa Chandler, who passed away on August 31. Her passion for research and compassion for others touched many, helping to advance work on triple-negative breast cancer and brain metastases.
Read more: https://t.co/4LWPd3fI6w
We celebrate the life and work of advocate member Jill Tirabassi, who passed away on September 7, 2026. A dedicated physician, researcher, educator and advocate, Jill’s work helped raise awareness for postpartum breast cancer.
Read more: https://t.co/JZIjGUVHHE
Join Dr. Ann Partridge (@AnnPartridgeMD), and Miranda McKeon for a free @BCRFcure webinar, “Younger Women and Breast Cancer: A Race for Answers.”
📅 Thursday, September 24 | 12 p.m. ET
Together, they’ll separate fact from fiction, discuss risk and prevention, and explore what advances in treatment mean for longevity and quality of life. The conversation will also cover menopause, hormone replacement therapy, and other topics younger women are asking about today.
Learn more and register: https://t.co/CHGQ58vxAD
#BreastCancer #BreastCancerInYoungWomen
Last year we lost our friend Shirley Mertz, who would have been 80 on 16/9. US President Barack Obama named her a “Champion of Change in Breast Cancer” for her work in ABC, and she received our ABC6 Award. Shirley's legacy of work for people with ABC lives on-we are so grateful.
FDA grants accelerated approval to Etcamah (camizestrant) + CDK4/6i (abemaciclib, palbociclib, ribociclib) for HR+/HER2- advanced BC upon ESR1 mutation detected during AI + CDK4/6i therapy, by FDA-authorized test.
Pro: mPFS 16 vs 9.2 mo per label. In SERENA-6, final PFS2 25.7 vs 19.1 mo (HR 0.63) and 46% lower risk of deterioration in global health status/QOL.
Con: Accelerated approval, OS immature, confirmatory trials required. Boxed warning for irregular heart rhythm with certain concomitant meds, plus bradycardia.
First trial to intervene on molecular resistance in breast cancer before clinical PD.
#bcsm
Intramural NCI, Center for Cancer Research (CCR) is looking to hire tenure track investigators, with Ph.D or MD or MD/Ph.D. Through the NIH Stadtman Scholars Program. Please see below for details. https://t.co/GlAVgiOuHI
A treasured 🎁 arrived yesterday: Anne Loeser’s(@AnnePCDI) “The Insider’s Guide to Metastatic Breast Cancer.”
Anne died from MBC in 2023. I had the privilege of working w/ @amybeumer, who died from MBC in June 2026, & @stage4kelly to update Anne’s book.
💔 that neither got to see it published. Grateful to have called them both friends. Their legacies live on. #bcsm @The_Right_Dose